Viking Therapeutics Inc.’s stock rose 2% Friday as excitement continued to build about data on its oral weight-loss drug the company will present at the upcoming Obesity Week event. The stock which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet,

People taking phentermine can lose over 7% of their body weight, or at least 8 pounds.

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories of the American company Viking Therapeutics, which has achieved a